BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chatterjee B, Gorain B, Mohananaidu K, Sengupta P, Mandal UK, Choudhury H. Targeted drug delivery to the brain via intranasal nanoemulsion: Available proof of concept and existing challenges. Int J Pharm 2019;565:258-68. [PMID: 31095983 DOI: 10.1016/j.ijpharm.2019.05.032] [Cited by in Crossref: 42] [Cited by in F6Publishing: 62] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Diedrich C, Camargo Zittlau I, Schineider Machado C, Taise Fin M, Maissar Khalil N, Badea I, Mara Mainardes R. Mucoadhesive nanoemulsion enhances brain bioavailability of luteolin after intranasal administration and induces apoptosis to sh-sy5y neuroblastoma cells. Int J Pharm 2022;:122142. [PMID: 36064075 DOI: 10.1016/j.ijpharm.2022.122142] [Reference Citation Analysis]
2 Zhao K, Xie Y, Lin X, Xu W. . IJN 2022;Volume 17:4579-98. [DOI: 10.2147/ijn.s359118] [Reference Citation Analysis]
3 Jiang Y, Jiang Y, Ding Z, Yu Q. Investigation of the “Nose-to-Brain” Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability. IJN 2022;Volume 17:3443-56. [DOI: 10.2147/ijn.s369978] [Reference Citation Analysis]
4 Utomo E, Domínguez-Robles J, Moreno-Castellanos N, Stewart SA, Picco C, Kurnia Anjani Q, Ander Simón J, Peñuelas I, Donnelly RF, Larrañeta E. Development of intranasal implantable devices for schizophrenia treatment. Int J Pharm 2022;:122061. [PMID: 35908633 DOI: 10.1016/j.ijpharm.2022.122061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jeong S, Jang J, Lee Y. Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig . [DOI: 10.1007/s40005-022-00589-5] [Reference Citation Analysis]
6 Wu Y, Rakotoarisoa M, Angelov B, Deng Y, Angelova A. Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery. Nanomaterials 2022;12:2267. [DOI: 10.3390/nano12132267] [Reference Citation Analysis]
7 Bashyal S, Thapa C, Lee S. Recent progresses in exosome-based systems for targeted drug delivery to the brain. J Control Release 2022;348:723-44. [PMID: 35718214 DOI: 10.1016/j.jconrel.2022.06.011] [Reference Citation Analysis]
8 Zha S, Wong KL, All AH. Intranasal Delivery of Functionalized Polymeric Nanomaterials to the Brain. Adv Healthc Mater 2022;11:e2102610. [PMID: 35166052 DOI: 10.1002/adhm.202102610] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
9 Tai J, Han M, Lee D, Park I, Lee SH, Kim TH. Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics 2022;14:1073. [DOI: 10.3390/pharmaceutics14051073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wei T, Thakur SS, Liu M, Wen J. Oral delivery of glutathione: antioxidant function, barriers and strategies. Acta Materia Medica 2022;1. [DOI: 10.15212/amm-2022-0005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Cunha S, Swedrowska M, Bellahnid Y, Xu Z, Sousa Lobo J, Forbes B, Silva A. Thermosensitive in situ hydrogels of rivastigmine-loaded lipid-based nanosystems for nose-to-brain delivery: characterisation, biocompatibility, and drug deposition studies. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121720] [Reference Citation Analysis]
12 Pandey M, Jain N, Kanoujia J, Hussain Z, Gorain B. Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System. Front Pharmacol 2022;13:865590. [DOI: 10.3389/fphar.2022.865590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zuglianello C, Lemos-Senna E. The nanotechnological approach for nasal delivery of peptide drugs: a comprehensive review. J Microencapsul 2022;:1-29. [PMID: 35262455 DOI: 10.1080/02652048.2022.2051626] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chavda VP, Vihol D, Mehta B, Shah D, Patel M, Vora LK, Pereira-Silva M, Paiva-Santos AC. Phytochemical-loaded liposomes for anticancer therapy: an updated review. Nanomedicine (Lond) 2022. [PMID: 35259920 DOI: 10.2217/nnm-2021-0463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
15 Yokel RA. Direct nose to the brain nanomedicine delivery presents a formidable challenge. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1767. [PMID: 34957707 DOI: 10.1002/wnan.1767] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Brookes A, Ji L, Bradshaw TD, Stocks M, Gray D, Butler J, Gershkovich P. Is Oral Lipid-Based Delivery for Drug Targeting to the Brain Feasible? Eur J Pharm Biopharm 2022:S0939-6411(22)00025-X. [PMID: 35149190 DOI: 10.1016/j.ejpb.2022.02.004] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Karthika C, Appu AP, Akter R, Rahman MH, Tagde P, Ashraf GM, Abdel-Daim MM, Hassan SSU, Abid A, Bungau S. Potential innovation against Alzheimer's disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery. Environ Sci Pollut Res Int 2022;29:10950-65. [PMID: 35000160 DOI: 10.1007/s11356-021-17830-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
18 Taliyan R, Kakoty V, Sarathlal KC, Kharavtekar SS, Karennanavar CR, Choudhary YK, Singhvi G, Riadi Y, Dubey SK, Kesharwani P. Nanocarrier mediated drug delivery as an impeccable therapeutic approach against Alzheimer's disease. J Control Release 2022:S0168-3659(22)00058-X. [PMID: 35114208 DOI: 10.1016/j.jconrel.2022.01.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 A P, Agrawal M, Dethe MR, Ahmed H, Yadav A, Gupta U, Alexander A. Nose-to-brain drug delivery for the treatment of Alzheimer's Disease: Current advancements and challenges. Expert Opin Drug Deliv 2022. [PMID: 35040728 DOI: 10.1080/17425247.2022.2029845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Lee D, Minko T. Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier. Pharmaceutics 2021;13:2049. [PMID: 34959331 DOI: 10.3390/pharmaceutics13122049] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Hu J, Tan X, Wang D, Li Y, Liang H, Peng J, Li F, Zhou Q, Geng P, Wang S, Yu Y, Liu J. A stepwise-targeting strategy for the treatment of cerebral ischemic stroke. J Nanobiotechnology 2021;19:371. [PMID: 34789285 DOI: 10.1186/s12951-021-01118-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Riccardi C, Napolitano F, Montesarchio D, Sampaolo S, Melone MAB. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics 2021;13:1897. [PMID: 34834311 DOI: 10.3390/pharmaceutics13111897] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
23 Bhanderi M, Shah J, Gorain B, Nair AB, Jacob S, Asdaq SMB, Fattepur S, Alamri AS, Alsanie WF, Alhomrani M, Nagaraja S, Anwer MK. Optimized Rivastigmine Nanoparticles Coated with Eudragit for Intranasal Application to Brain Delivery: Evaluation and Nasal Ciliotoxicity Studies. Materials (Basel) 2021;14:6291. [PMID: 34771817 DOI: 10.3390/ma14216291] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Singh A, Mallika TN, Gorain B, Yadav AK, Tiwari S, Flora S, Shukla R, Kesharwani P. Quantum dot: Heralding a brighter future in neurodegenerative disorders. Journal of Drug Delivery Science and Technology 2021;65:102700. [DOI: 10.1016/j.jddst.2021.102700] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Tripathi S, Gupta U, Ujjwal RR, Yadav AK. Nano-lipidic formulation and therapeutic strategies for Alzheimer's disease via intranasal route. J Microencapsul 2021;38:572-93. [PMID: 34591731 DOI: 10.1080/02652048.2021.1986585] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Gadhave D, Tupe S, Tagalpallewar A, Gorain B, Choudhury H, Kokare C. Nose-to-brain delivery of amisulpride-loaded lipid-based poloxamer-gellan gum nanoemulgel: In vitro and in vivo pharmacological studies. Int J Pharm 2021;607:121050. [PMID: 34454028 DOI: 10.1016/j.ijpharm.2021.121050] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
27 Xue F, Li X, Qin L, Liu X, Li C, Adhikari B. Anti-aging properties of phytoconstituents and phyto-nanoemulsions and their application in managing aging-related diseases. Adv Drug Deliv Rev 2021;176:113886. [PMID: 34314783 DOI: 10.1016/j.addr.2021.113886] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
28 Emad NA, Ahmed B, Alhalmi A, Alzobaidi N, Al-kubati SS. Recent progress in nanocarriers for direct nose to brain drug delivery. Journal of Drug Delivery Science and Technology 2021;64:102642. [DOI: 10.1016/j.jddst.2021.102642] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
29 Handa M, Tiwari S, Yadav AK, Almalki WH, Alghamdi S, Alharbi KS, Shukla R, Beg S. Therapeutic potential of nanoemulsions as feasible wagons for targeting Alzheimer's disease. Drug Discov Today 2021:S1359-6446(21)00325-1. [PMID: 34332094 DOI: 10.1016/j.drudis.2021.07.020] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
30 Lombardo R, Musumeci T, Carbone C, Pignatello R. Nanotechnologies for intranasal drug delivery: an update of literature. Pharm Dev Technol 2021;26:824-45. [PMID: 34218736 DOI: 10.1080/10837450.2021.1950186] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Cunha S, Forbes B, Sousa Lobo JM, Silva AC. Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels. Int J Nanomedicine 2021;16:4373-90. [PMID: 34234432 DOI: 10.2147/IJN.S305851] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
32 Feng J, Ma Y, Chen Z, Liu Q, Yang J, Gao Y, Chen W, Qian K, Yang W. Development and Characterization of Pyriproxyfen-Loaded Nanoemulsion for Housefly Control: Improving Activity, Reducing Toxicity, and Protecting Ecological Environment. ACS Sustainable Chem Eng 2021;9:4988-99. [DOI: 10.1021/acssuschemeng.0c08105] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
33 Kotta S, Mubarak Aldawsari H, Badr-Eldin SM, Alhakamy NA, Md S. Coconut oil-based resveratrol nanoemulsion: Optimization using response surface methodology, stability assessment and pharmacokinetic evaluation. Food Chem 2021;357:129721. [PMID: 33866243 DOI: 10.1016/j.foodchem.2021.129721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
34 Shah B. Microemulsion as a promising carrier for nose to brain delivery: journey since last decade. J Pharm Investig 2021;51:611-34. [DOI: 10.1007/s40005-021-00528-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Patnaik S, Gorain B, Padhi S, Choudhury H, Gabr GA, Md S, Kumar Mishra D, Kesharwani P. Recent update of toxicity aspects of nanoparticulate systems for drug delivery. European Journal of Pharmaceutics and Biopharmaceutics 2021;161:100-19. [DOI: 10.1016/j.ejpb.2021.02.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
36 Gao Y, Wang R, Zhao L, Liu A. Natural polymeric nanocarriers in malignant glioma drug delivery and targeting. J Drug Target 2021;:1-48. [PMID: 33745392 DOI: 10.1080/1061186X.2021.1904250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Tran PHL, Tran TTD. Nano-sized Solid Dispersions for Improving the Bioavailability of Poorly Water-soluble Drugs. Curr Pharm Des 2020;26:4917-24. [PMID: 32611298 DOI: 10.2174/1381612826666200701134135] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
38 Shukr MH, Farid OAA. Brain targeting of agomelatine egg lecithin based chitosan coated nanoemulsion. Pharm Dev Technol 2021;26:464-75. [PMID: 33586593 DOI: 10.1080/10837450.2021.1888980] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Kumbhar SA, Kokare CR, Shrivastava B, Gorain B, Choudhury H. Antipsychotic Potential and Safety Profile of TPGS-Based Mucoadhesive Aripiprazole Nanoemulsion: Development and Optimization for Nose-To-Brain Delivery. J Pharm Sci 2021;110:1761-78. [PMID: 33515583 DOI: 10.1016/j.xphs.2021.01.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
40 Qu Y, Li A, Ma L, Iqbal S, Sun X, Ma W, Li C, Zheng D, Xu Z, Zhao Z, Ma D. Nose-to-brain delivery of disulfiram nanoemulsion in situ gel formulation for glioblastoma targeting therapy. Int J Pharm 2021;597:120250. [PMID: 33486040 DOI: 10.1016/j.ijpharm.2021.120250] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
41 Matarazzo AP, Elisei LMS, Carvalho FC, Bonfílio R, Ruela ALM, Galdino G, Pereira GR. Mucoadhesive nanostructured lipid carriers as a cannabidiol nasal delivery system for the treatment of neuropathic pain. Eur J Pharm Sci 2021;159:105698. [PMID: 33406408 DOI: 10.1016/j.ejps.2020.105698] [Cited by in Crossref: 4] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
42 Chen Y, Liu Y, Xie J, Zheng Q, Yue P, Chen L, Hu P, Yang M. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine. Int J Nanomedicine 2020;15:10435-51. [PMID: 33380794 DOI: 10.2147/IJN.S265659] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Bahadur S, Pardhi DM, Rautio J, Rosenholm JM, Pathak K. Intranasal Nanoemulsions for Direct Nose-to-Brain Delivery of Actives for CNS Disorders. Pharmaceutics 2020;12:E1230. [PMID: 33352959 DOI: 10.3390/pharmaceutics12121230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
44 Choudhury H, Pandey M, Wen LP, Cien LK, Xin H, Yee ANJ, Lee NJ, Gorain B, Amin MCIM, Pichika MR. Folic Acid Conjugated Nanocarriers for Efficient Targetability and Promising Anticancer Efficacy for Treatment of Breast Cancer: A Review of Recent Updates. CPD 2020;26:5365-79. [DOI: 10.2174/1381612826666200721000958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
45 Alves LP, da Silva Oliveira K, da Paixão Santos JA, da Silva Leite JM, Rocha BP, de Lucena Nogueira P, de Araújo Rêgo RI, Oshiro-junior JA, Damasceno BPGDL. A review on developments and prospects of anti-inflammatory in microemulsions. Journal of Drug Delivery Science and Technology 2020;60:102008. [DOI: 10.1016/j.jddst.2020.102008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
46 da Silva Santos J, Diedrich C, Machado CS, da Fonseca CO, Khalil NM, Mainardes RM. Intranasal administration of perillyl alcohol-loaded nanoemulsion and pharmacokinetic study of its metabolite perillic acid in plasma and brain of rats using ultra-performance liquid chromatography/tandem mass spectrometry. Biomed Chromatogr 2021;35:e5037. [PMID: 33238042 DOI: 10.1002/bmc.5037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Zhang L, Yang S, Wong LR, Xie H, Ho PC. In Vitro and In Vivo Comparison of Curcumin-Encapsulated Chitosan-Coated Poly(lactic-co-glycolic acid) Nanoparticles and Curcumin/Hydroxypropyl-β-Cyclodextrin Inclusion Complexes Administered Intranasally as Therapeutic Strategies for Alzheimer's Disease. Mol Pharm 2020;17:4256-69. [PMID: 33084343 DOI: 10.1021/acs.molpharmaceut.0c00675] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
48 Zhang L, Yang S, Huang L, Ho PC. Poly (ethylene glycol)-block-poly (D, L-lactide) (PEG-PLA) micelles for brain delivery of baicalein through nasal route for potential treatment of neurodegenerative diseases due to oxidative stress and inflammation: An in vitro and in vivo study. Int J Pharm 2020;591:119981. [PMID: 33069896 DOI: 10.1016/j.ijpharm.2020.119981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
49 Inoue D, Furubayashi T, Tanaka A, Sakane T, Sugano K. Effect of Cerebrospinal Fluid Circulation on Nose-to-Brain Direct Delivery and Distribution of Caffeine in Rats. Mol Pharm 2020;17:4067-76. [PMID: 32955898 DOI: 10.1021/acs.molpharmaceut.0c00495] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
50 Shringarpure M, Gharat S, Momin M, Omri A. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery. Expert Opin Drug Deliv 2021;18:169-85. [PMID: 32921169 DOI: 10.1080/17425247.2021.1823965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
51 Kischkel B, Rossi SA, Santos SR, Nosanchuk JD, Travassos LR, Taborda CP. Therapies and Vaccines Based on Nanoparticles for the Treatment of Systemic Fungal Infections. Front Cell Infect Microbiol 2020;10:463. [PMID: 33014889 DOI: 10.3389/fcimb.2020.00463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
52 Azarmi M, Maleki H, Nikkam N, Malekinejad H. Transcellular brain drug delivery: A review on recent advancements. International Journal of Pharmaceutics 2020;586:119582. [DOI: 10.1016/j.ijpharm.2020.119582] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
53 Agrawal M, Saraf S, Saraf S, Dubey SK, Puri A, Gupta U, Kesharwani P, Ravichandiran V, Kumar P, Naidu VGM, Murty US, Ajazuddin, Alexander A. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J Control Release 2020;327:235-65. [PMID: 32739524 DOI: 10.1016/j.jconrel.2020.07.044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 51] [Article Influence: 11.5] [Reference Citation Analysis]
54 Rinaldi F, Oliva A, Sabatino M, Imbriano A, Hanieh PN, Garzoli S, Mastroianni CM, De Angelis M, Miele MC, Arnaut M, Di Timoteo F, Marianecci C, Ragno R, Carafa M. Antimicrobial Essential Oil Formulation: Chitosan Coated Nanoemulsions for Nose to Brain Delivery. Pharmaceutics 2020;12:E678. [PMID: 32709076 DOI: 10.3390/pharmaceutics12070678] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
55 Gorain B, Rajeswary DC, Pandey M, Kesharwani P, Kumbhar SA, Choudhury H. Nose to Brain Delivery of Nanocarriers Towards Attenuation of Demented Condition. CPD 2020;26:2233-46. [DOI: 10.2174/1381612826666200313125613] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
56 Kumbhar SA, Kokare CR, Shrivastava B, Gorain B, Choudhury H. Preparation, characterization, and optimization of asenapine maleate mucoadhesive nanoemulsion using Box-Behnken design: In vitro and in vivo studies for brain targeting. Int J Pharm 2020;586:119499. [PMID: 32505580 DOI: 10.1016/j.ijpharm.2020.119499] [Cited by in Crossref: 15] [Cited by in F6Publishing: 21] [Article Influence: 7.5] [Reference Citation Analysis]
57 Ojeda-Hernández DD, Canales-Aguirre AA, Matias-Guiu J, Gomez-Pinedo U, Mateos-Díaz JC. Potential of Chitosan and Its Derivatives for Biomedical Applications in the Central Nervous System. Front Bioeng Biotechnol 2020;8:389. [PMID: 32432095 DOI: 10.3389/fbioe.2020.00389] [Cited by in Crossref: 15] [Cited by in F6Publishing: 37] [Article Influence: 7.5] [Reference Citation Analysis]
58 Gorain B, Choudhury H, Nair AB, Dubey SK, Kesharwani P. Theranostic application of nanoemulsions in chemotherapy. Drug Discov Today 2020;25:1174-88. [PMID: 32344042 DOI: 10.1016/j.drudis.2020.04.013] [Cited by in Crossref: 21] [Cited by in F6Publishing: 35] [Article Influence: 10.5] [Reference Citation Analysis]
59 Inoue D, Furubayashi T, Tanaka A, Sakane T, Sugano K. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats. European Journal of Pharmaceutics and Biopharmaceutics 2020;149:145-53. [DOI: 10.1016/j.ejpb.2020.02.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
60 de Lourdes Pérez-gonzález ML, González-de la Rosa CH, Pérez-hernández G, Beltrán HI. Nanostructured oleic acid/polysorbate 80 emulsions with diminished toxicity in NL-20 cell line: Insights of potential drug carriers. Colloids and Surfaces B: Biointerfaces 2020;187:110758. [DOI: 10.1016/j.colsurfb.2019.110758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Nirale P, Paul A, Yadav KS. Nanoemulsions for targeting the neurodegenerative diseases: Alzheimer's, Parkinson's and Prion's. Life Sci 2020;245:117394. [PMID: 32017870 DOI: 10.1016/j.lfs.2020.117394] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
62 Choudhury H, Zakaria NFB, Tilang PAB, Tzeyung AS, Pandey M, Chatterjee B, Alhakamy NA, Bhattamishra SK, Kesharwani P, Gorain B, Md S. Formulation development and evaluation of rotigotine mucoadhesive nanoemulsion for intranasal delivery. Journal of Drug Delivery Science and Technology 2019;54:101301. [DOI: 10.1016/j.jddst.2019.101301] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 6.7] [Reference Citation Analysis]
63 Rehman S, Nabi B, Zafar A, Baboota S, Ali J. Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson's disease treatment? Expert Opin Drug Deliv 2019;16:1355-66. [PMID: 31663382 DOI: 10.1080/17425247.2019.1684895] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]